Russell Pachynski, MD, Associate Professor, WashU Division of Oncology, received the 2024 Harrington Scholar-Innovator Award for research work on – Tumor-Targeted Therapeutic that Recruits Immune Cells.
Harrington Discovery Institute was established in 2012 to accelerate the development of new treatments to address major unmet needs in medicine and society. Since its founding, Harrington has supported 188 drugs-in-the-making, 66 institutions, 39 company launches, 21 clinical candidates, and 15 licenses to pharma.
“Harrington Scholar-Innovators are accomplished physician-scientists whose research demonstrates innovation, creativity and the potential for clinical impact. In surrounding each scholar with an experienced pharma and business development team, we are maximizing the therapeutic potential of great science,”
Jonathan S. Stamler, MD
President, Harrington Discovery Institute, Distinguished University Professor and Robert S. and Sylvia K. Reitman Family Foundation Professor of Cardiovascular Innovation at University Hospitals and Case Western Reserve University
“This extraordinary group of physician-scientists constitutes Harrington’s twelfth class of Scholar-Innovators. We are excited to help them advance their discoveries towards patients in need,” said Seth Field, MD, PhD, Director, Physician-Scientist Programs and Investigator, Harrington Discovery Institute and Becky Hennessy Endowed Master Clinician in Breast Cancer Genomics.